Multi-drug implications for COVID-19 treatment, opioid safety, and quality measures

This webinar reviews pharmacokinetic and pharmacodynamic concerns with opioids, potential COVID-19 treatment options, and medication use in older adults. Through case examples, it provides insight into how technology, such as MedWise™, can be leveraged to reduce medication-related problems and improve patient outcomes.

MedWise, our medication safety platform, enhances medication reviews by identifying accumulative, simultaneous, multi-drug interactions. MedWise presents actionable opportunities to mitigate risks, demonstrating improved outcomes, reduced costs, and a 5:1 return on investment. Analyze your entire member population to identify and predict which members will clinically benefit from our medication risk mitigation technology. Request your free analysis report!

https://www.tabularasahealthcare.com/medwise-information/

Access the recorded webinar